newsfilter
← Earnings
Earnings Releases·

STERIS — Fiscal 2027 Second Quarter Earnings Summary

STERIS reported a 9% increase in fiscal 2027 second-quarter revenue to $1.6 billion, driven by constant currency organic growth of 8%. Diluted earnings per share rose to $2.19 on an as-reported basis, while adjusted diluted EPS reached $2.94, reflecting a $20 million benefit from tariff refunds. The company updated its full-year fiscal 2027 outlook, raising adjusted earnings per share expectations to a range of $11.35 to $11.55 due to solid underlying performance and tariff benefits. Additionally, STERIS announced a new targeted restructuring plan with approximately $45 million in total charges aimed at generating annualized savings of $9 million.

Company
STERIS PLC
Sector
Healthcare
Industry
Medical Devices